Tag: Relacorilant

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Relacorilant

Corcept Therapeutics (CORT) Downgraded by Zacks Investment Research

Added to Collection on: 2018-01-05 20:49:54

Tags for this article:

Money
Finance
Stock
Financial markets
Short
Price?earnings ratio
Chemistry
Corcept Therapeutics
Relacorilant

Click the tags to see associated articles and topics

View Article Details
10-15 Associates Cut By $4.04 Million Its Intel (INTC) Stake; Corcept Therapeutics (CORT) Shorts ...

Added to Collection on: 2018-06-13 04:15:00

Tags for this article:

Economy
Intel
NASDAQ
Short
Chemistry
Intel Corp.
Teva Pharmaceutical Industries
Corcept Therapeutics
Relacorilant

Click the tags to see associated articles and topics

View Article Details
The Insider and Chief Medical Officer of Corcept Therapeutics (CORT), Robert Fishman, Sold 8000 ...

Added to Collection on: 2018-11-19 00:13:31

Tags for this article:

Finance
NASDAQ
Chemistry
TSMC
Organic chemistry
Taiwan Semiconductor Manufacturing Company Limited
Celgene
Corcept Therapeutics
Taiwan Semiconductor Mfg Ltd
Relacorilant
2330.TW
TSM.N
N-Shares

Click the tags to see associated articles and topics

View Article Details
Cantor Fitzgerald Gives Corcept Therapeutics (CORT) $29 Target; 3D Systems (DDD) Shorts ...

Added to Collection on: 2018-12-11 21:32:53

Tags for this article:

NASDAQ
Economy of the United States
Short
Chemistry
New York Stock Exchange
3D Systems
Organic chemistry
Corcept Therapeutics
Relacorilant
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Cushing's Syndrome Pipeline Advances with a Heightened R&D, Expected Entry of Several Novel ...

Added to Collection on: 2021-05-27 00:00:00

Tags for this article:

Chemical compounds
Organic compounds
Drugs
Acetamides
CYP17A1 inhibitors
Chloroarenes
Dioxolanes
Adrenal gland disorders
Cushing's syndrome
Relacorilant
Corcept Therapeutics
Levoketoconazole

Click the tags to see associated articles and topics

View Article Details
Corcept Will Seek FDA Approval of Relacorilant in 2023 - Cushing's Disease News

Added to Collection on: 2022-02-18 18:23:59

Tags for this article:

Chemical compounds
Organic compounds
Organ systems
Glucocorticoids
Adrenal gland disorders
Hepatotoxins
Corcept Therapeutics
Cushing's syndrome
Cortisol
Relacorilant
Adrenal gland
Adrenocortical hormone
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details